WDPrx – Woodfield Pharmaceutical, LLC is a proven and reliable CMO pharma partner specializing in oral solutions, liquid solutions, suspensions and semi-solids. We increase efficiency ‘from lab to launch’ managing early stage development, R+D, technology transfer, pharmaceutical formulation and development, exhibit batches, ANDA and NDA regulatory support.   Serialization Accomplished The requirements for pharmaceutical serialization compliance were completed at WDPrx last year with t...

The current business climate favors forward-thinking contract manufacturing organizations that improve ties with manufacturers for services across the entire value chain, writes WDPrx President Adam Runsdorf in the May 2018 issue of Contract Pharma magazine. Read the article on the Contract Pharma site. The relationship of pharmaceutical manufacturers with contract manufacturing organizations (CMO) and contract development and manufacturing organizations (CDMO) is increasingly evolving from one-...

WDPrx continues to expand business opportunities with industry outreach and news stories highlighting our full range of development, manufacturing and testing capabilities. Click here to read the most recent update....

A version of this story appeared in the June 2017 issue of Contract Pharma Magazine under the title “Adapt Or Die.” Adapt Or Die As companies within the pharmaceutical supply chain near the November 27, 2017 deadline for the most recent phase of DSCSA compliance, contract packaging operations with comprehensive serialization implementation programs will see their business increase due to the new requirements. A primary goal of the DSCSA is improving information transparency to minimi...

...